(2023) proposed Azocarus sp
It is a powerful antioxidant that functions by reducing reactive oxygen species
Secondary outcomes The secondary outcomes are as follows: type 2 diabetes, glucose, HbA1c, insulin, lipid profile (LDL-cholesterol, HDL-cholesterol, triglycerides and apolipoprotein B), systolic blood pressure, diastolic blood pressure, and body mass index (BMI), which are well-established risk factors for CVD in clinical practice, or recently identified to be related to CVD in MR, such as apolipoprotein B [30, 31]
Related Reading Medication Glp 1 Glp 1 Medications Do Genetic Tests Help Identify People Who Will Benefit From Glp 1 Medications Can A Dna Test Reveal If I Will Benefit From Glp 1 Medications Medical and Editorial Standards Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims
Natural antioxidants in the cell neutralize many of the free radicals